Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01648
Species: Homo sapiens
Position : chr8:128740000-128750000
Year: 2024
Title: RUNX1 C-terminal mutations impair blood cell differentiation by perturbing specific enhancer-promoter networks
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: chronic myeloid leukemia
PMID:  38513139
MONDO: MONDO:0011998
Tissue: Blood
Tissue Ontology ID: UBERON:0000178
Cell Source: K562
CVCL ID: CVCL_0004
Cell Type: chronic myeloid leukemia cell
Cell Ontology ID: CL:0001054
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: ChIP-seq, GRID-seq, RNA-seq
Low Throughput Method: CUT&RUN-RT-qPCR, shRNA Knockdown, RT-RT-qPCR, Western blot
About Target Gene
Target gene : MYC
About TF
TF name : RUNX1; RUNX1R320*; FOXK2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 3 found
Enhancer ID Position Tissue Cell Disease
E_01708 chr8:126650000-129950000 Colon colorectal carcinoma cell colorectal carcinoma
E_01307 chr8:128747000-128748000 Blood chronic myeloid leukemia cell chronic myeloid leukemia
E_01847 chr8:128747000-128748000 Colon colorectal carcinoma cell colorectal carcinoma
Expression of Target Genes for the Enhancer